Rafinlar 75mg Capsule
Marketer
Novartis India Ltd
Salt Composition
Dabrafenib (75mg)
Overview Rafinlar 75mg Capsule
Encorafenib 75mg capsules treat malignant melanoma, a skin cancer. Other uses may be determined by your physician. Take Encorafenib 75mg one hour before or two hours after meals, as directed. Treatment length depends on your response. Regular eye exams are recommended. Report any eye irritation, blurred vision, pain, or visual changes immediately. Common side effects include diarrhea, fever, nausea, and headache; persistent or worsening symptoms should be reported. Serious side effects are possible; this medication can weaken the immune system and affect blood, liver, or kidney function. Report unusual bleeding, fatigue, appetite loss, or jaundice. Regular blood tests will be necessary. Inform your doctor of liver or kidney issues, or any infection medications, before starting treatment. This medication may interact with others; disclose all medications to your physician. It's contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners during treatment. A patient support program is available in India through Tata 1mg; contact your doctor or call 1800-102-1618 for details.
Uses of Rafinlar 75mg Capsule
Managing metastatic melanoma
Major Benefits of Rafinlar 75mg Capsule:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Consume each 75mg Rafinlar capsule on an empty stomach.
Common Side effects of Rafinlar 75mg Capsule:
- Diarrhea
- Fever
- Nausea
- Chills
- Headache
- Joint pain
- Cough
- Muscle pain
- Swelling
How to use Rafinlar 75mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume each 75mg Rafinlar capsule on an empty stomach.
How Rafinlar 75mg Capsule works:
Melanoma patients may be prescribed Rafinlar 75mg Capsules, an anticancer drug. This medication targets and inhibits BRAF, a mutated protein responsible for controlling cell division. The BRAF mutation accelerates cellular growth, leading to the development of melanoma.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining Rafinlar 75mg Capsule with alcohol is undetermined. Seek medical advice before consuming alcohol while taking this medication.
PregnancyCONSULT YOUR DOCTOR
The use of Rafinlar 75mg Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
Use of 75mg Rafinlar capsules while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by the use of Rafinlar 75mg Capsules, which may produce adverse effects.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, 75mg Rafinlar capsules may be administered without dosage modification.
LiverSAFE IF PRESCRIBED
For individuals with hepatic impairment, Rafinlar 75mg capsules are considered safe for administration. Dosage modification of Rafinlar 75mg capsules is unnecessary.
What if you forget to take Rafinlar 75mg Capsule :
NA
Facts to Know About Rafinlar 75mg Capsule
| Label | Value |
|---|---|
| Chemical Type | Sulfonamide |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently